Henry Schein, Inc. (Nasdaq:HSIC) Chairman of the Board and Chief Executive Officer Stanley M. Bergman submitted a letter to the House Select Subcommittee on the Coronavirus Crisis, urging federal officials to include primary care physicians and other office-based practitioners, including dentists, in the effort to expand COVID vaccination nationwide.

“More effectively activating the vast network of physicians and dentists in the U.S. to join the fight to vaccinate Americans is critical at this moment in the country’s vaccination efforts,” Mr. Bergman wrote. “Not only are [these healthcare professionals] capable of helping individuals overcome hesitancy, but their offices span zip codes across the U.S. in ways that other vaccine distribution systems do not. From inner cities and suburbs to rural areas and farmland, doctors are a part of almost every community. Their administration of the annual flu shot demonstrates that doctors have the infrastructure to deliver the Covid-19 shot, especially as public health authorities increasingly suggest a long-term need for booster shots of the Covid-19 vaccine.

“We urge the Administration and HHS to consider providing office-based practitioners, regardless of in which state they practice, meaningful access to the vaccine as part of our vaccine rollout,” Mr. Bergman wrote.

The letter was submitted as a statement for the record in conjunction with the Select Subcommittee’s hearing featuring testimony from Centers for Disease Control and Prevention Director Dr. Rochelle P. Walensky, National Institute of Allergy and Infectious Diseases Director Dr. Anthony S. Fauci, and Chief Science Officer for COVID Response Dr. David Kessler. 

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more

efficiently so they can provide quality care more effectively. These solutions also support dental and medical laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries and territories. The Company's sales reached $10.1 billion in 2020, and have grown at a compound annual rate of approximately 12 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, and Twitter.com/HenrySchein

Thanks to Keating Dental Lab, the Baylor Men’s basketball team, and the generosity of a dental industry marketing professional, Dental Lifeline Network (DLN) was a big winner in this year’s NCAA tourney.

Each year, Keating Dental Lab sponsors an NCAA Tournament bracket challenge, free to enter and open to all, with a grand prize of $3,000 for the winning bracket.

This year, Derek Van Volkom, who works for Lanmark360, an advertising agency in the dental space, entered for the first time. “I was on the Keating website and I thought, why not? I picked a few long shots like Oral Roberts University and UCLA, and of course, Baylor to win it all.”

Derek won the Keating bracket challenge—and donated the entire $3,000 winner’s check to the Dental Lifeline Network (DLN). “I decided to pay it forward and be charitable to an organization that does so much for dentistry—the industry that has supported my company and me personally for over 20 years,” said Derek. “It was like found money, and the DLN is a very worthy cause. It’s a nonprofit that provides free dental services to veterans, disabled, and elderly patients who don’t have insurance.”

“I was super excited to see this year’s winner donate the prize money to a great cause,” said Shaun Keating, CDT, of Keating Dental Lab. Coincidentally, Keating Labs has supported DLN for years, donating hundreds of cases to their Donated Dental Services program.

“Our lab does a lot with veterans' groups and we always like to give back, so it’s great to see the winnings go to such an amazing organization dedicated to dentistry,” said Shaun.

“It was an amazing tournament, and donating the money just makes it a win-win for everyone,” said Derek.

Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company engaged in the design and manufacture of the Invisalign system, iTero intraoral scanners, and exocad CAD/CAM services for orthodontic and restorative dentistry, today announced plans to open a new manufacturing facility in Poland to address the large and underpenetrated market opportunity in the Europe, Middle East and Africa (EMEA) region, which represents over 5 million annual orthodontic case starts and more than 150 million EMEA consumers who can potentially benefit from a healthier, beautiful smile. The new Wroclaw plant will be Align’s first in the EMEA region and its third plant worldwide, joining Juarez, Mexico and Ziyang, China.

The new facility is expected to begin supplying customers in the EMEA region in early 2022. The investment is part of Align’s strategy to bring its operational facilities closer to its customers. Align works directly with doctors - dentists and orthodontists - to provide them with the Invisalign system of clear aligners to prescribe to their patients to straighten their teeth and transform their smiles.

“I’m excited to announce plans to open our first aligner manufacturing facility in the EMEA region, and third globally. This significant investment underscores our commitment to the more than 62,700 Invisalign trained doctors and their patients in the EMEA region and extends our local operations in the region that include treatment planning facilities (TREAT), based in Poland, Germany and Spain,” said Emory Wright, Align senior vice president, Global Operations.

Align Technology is the world’s largest 3D printing manufacturer, with as many as 700,000 unique aligner parts produced per day in its manufacturing facilities across the globe. The Invisalign system is leveraged by over 200,000 Invisalign trained dentists and orthodontists. More than 9.6 million patients have been treated with the Invisalign system worldwide, including 2 million patients in the EMEA region as of the fourth quarter of 2020.

"We are proud to open Align’s first manufacturing facility in the EMEA region. The state-of-the-art EMEA plant in Wroclaw is expected to add more than 2,500 jobs to Align by the end of 2025, making it the company’s largest investment in EMEA to date. Align has been expanding its presence in the region for the past 20 years by adding new offices, building strong regional and local teams, and expanding digital treatment planning facilities in three different markets – with plans for further expansion. This new investment will allow us to deliver on our ongoing commitment to Invisalign doctors in the region to support them with more dedicated, customized support, as well as quicker turnaround and delivery times,” added Markus Sebastian, Align senior vice president and managing director, EMEA.

“The development of Polish industry, using innovative technologies, is one of the key priorities of the Polish government, which has been highlighted in the Industrial Development Policy of Poland. We continue to create the best possible conditions to allow development of domestic companies, as well as encourage foreign capital to invest in our country. We consistently support investment in digitalization. Poland has some of the world's best specialists in digitization and support instruments, such as dedicated economic zones or the government grant program that significantly simplify the procedure for business development. We are pleased that another investor - Align Technology, has recognized these opportunities and decided to expand their presence in the EMEA region by planning to open the largest 3D printing and manufacturing plants in Poland,” said Polish Deputy Prime Minister Jaroslaw Gowin, Minister for Development, Labour and Technology.

“I am very pleased with Align Technology's decision to further develop its operations in Poland. The new project has a huge potential in terms of employment, with approximately 2,500 new jobs expected to be created. Digital transformation has changed the face of many industries and has found its place in the medical sector, which is best proved by Align, a company that uses 3D printing in production. It is worth emphasizing that the interest of the medical industry in the Polish market is still growing, as confirmed by inquiries of foreign companies coming to Polish Investment & Trade Agency (PAIH), with six medical investment projects and another five already underway. Technologies used in the medical sector are now very much needed by everyone,” added Krzysztof Drynda, Chairman of the Polish Investment and Trade Agency.

The new Align manufacturing facility will open in early 2022, with plans to support all EMEA Invisalign case shipments by 2024. The multi-million-dollar investment by Align is one of the larger projects by an international company in the greater Wroclaw area.

*total number of doctors trained in EMEA since Dec. 1998. Data on file.

About Align Technology, Inc.

Align Technology designs, manufactures and offers the Invisalign system, the most advanced clear aligner system in the world, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 200 thousand doctor customers and is key to accessing Align’s 500 million consumer market opportunity worldwide. Align has helped doctors treat over 9.6 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero systems and services, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

About the Invisalign system

Invisalign clear aligners are a removable and transparent teeth-straightening solution produced using digital and 3D technologies. This type of solution differs from other orthodontic devices in that they are more comfortable and can be easily removed for eating or drinking. Used to treat minor to complex types of malocclusions, Invisalign clear aligners are replaced every one or two weeks, depending on a doctor’s recommendation, gradually moving teeth towards the projected final position.

Forward-Looking Statements

This news release contains forward-looking statements, including quotations from management regarding the expected timing and benefits of its planned manufacturing facility in Poland, including the number of new positions, manufacturing and delivery times, and customer support. Forward-looking statements contained in this news release relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties, and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement.

Factors that might cause such a difference include, but are not limited to:

-the impact of the COVID-19 pandemic on the health and safety of our employees, customers, patients, and our suppliers, as well as the physical and economic impacts of the various recommendations, orders, and protocols issued by local and national governmental agencies in light of continual evolution of the pandemic, including any periodic reimplementation of preventative measures in various global locations;

-difficulties predicting customer and consumer purchasing behavior and changes in consumer spending habits as a result of, among other things, prevailing economic conditions, levels of employment, salaries and wages, and consumer confidence, particularly in light of the pandemic and as pandemic-related restrictions are eased regionally and globally;

-unexpected or rapid changes in the growth or decline of our domestic and/or international markets;

-increasing competition from existing and new competitors;

-rapidly evolving and groundbreaking advances that fundamentally alter the dental industry or the way new and existing customers market and provide products and services to consumers;

-the ability to protect our intellectual property rights;

-continued compliance with regulatory requirements;

-declines in, or the slowing of the growth of, sales of our intra-oral scanners domestically and/or internationally and the impact either would have on the adoption of Invisalign products;

-the willingness and ability of our customers to maintain and/or increase product utilization in sufficient numbers;

-the possibility that the development and release of new products or enhancements to existing products do not proceed in accordance with the anticipated timeline or may themselves contain bugs or errors requiring remediation and that the market for the sale of these new or enhanced products may not develop as expected;

-a tougher consumer demand environment in China generally, especially for manufacturers and service providers whose headquarters or primarily operations are not based in China;

-the risks relating to our ability to sustain or increase profitability or revenue growth in future periods (or minimize declines) while controlling expenses;

-the impact of excess or constrained capacity at our manufacturing and treat operations facilities and pressure on our internal systems and personnel;

-the compromise of customer and/or patient data for any reason;

-the timing of case submissions from our doctors within a quarter as well as an increased manufacturing costs per case;

-foreign operational, political and other risks relating to our international manufacturing operations; and

-the loss of key personnel or work stoppages.

The foregoing and other risks are detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including, but not limited to, our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2021. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason. 

The National Association of Dental Laboratories (NADL) and the National Board for Certification in Dental Laboratory Technology (NBC) honored outstanding contributors to dental laboratory technology at the annual Vision 21 Meeting on Saturday, April 10, at the Gaylord Opryland Resort in Nashville, Tennessee. Winners were nominated by their peers and were selected based on an objective point system.

The NADL awards Included:

NADL Laboratory Member of the Year: Burdette Dental Laboratory, Inc., CDL – Birmingham, AL

This award is presented to an NADL member laboratory that has made significant contributions and demonstrated leadership in relation to working in the dental laboratory industry. 

NADL Supplier Member of the Year: Carbon

This award is presented to an NADL member manufacturer/supplier company that has made significant contributions and demonstrated leadership in relation to working in the dental laboratory industry. 

The NBC awards Included:

2021 CDT of the Year: Edwin Kee, Master CDT, TE – LSU HSC School of Dentistry, CDL – New Orleans, LA

The National Board for Certification in Dental Laboratory Technology recognizes an individual Certified Dental Technician (CDT) who has made contributions to his/her peers and the dental laboratory profession, and has gone above and beyond the call of duty. 

 The Glidewell Implant Business Essentials Continuum is designed to train dentists how to incorporate essential business, leadership and practice management principles into their implant services. With guidance from leading instructors in their respective fields, covering everything from financial planning and tax strategies, to patient communications and case acceptance, to social media presence and ethics, attendees will leave with ties to a network of advanced practitioners and a completely original education that will put them ahead in the field of implant dentistry.

While Glidewell is known for offering a wide range of clinical courses, this continuum will focus more on practice development and business skills that doctors are not often exposed to in traditional continuing education curriculum on implant treatment. This shift in focus will give doctors the opportunity to develop a truly well-rounded education that will help them grow their practice as well as their confidence.

The continuum runs from October 2021 to January 2022 and will feature 11 online courses, culminating in a full day of events at the Glidewell Campus in Irvine, California, which will include an array of interactive courses, a tour of the largest dental technology campus in the world, and a yacht cruise in Newport Harbor. Attendees will earn a total of 23 CEUs when they complete the continuum, and a special early bird package price will allow dentists to save $600 if they sign up before July 31, 2021.

In order to deliver a genuine, deep study into such a wide range of topics, Glidewell is partnering with the Misch International Implant Institute for its world-renowned implant expertise, the Levin Group for its 35 years of experience in practice management consulting, and Aprio for its industry-leading financial advisory services. These partners bring their expertise to the curriculum so that doctors will be able to learn the secrets of implant business essentials from proven experts.

"Doctors invest significant time and money in learning the clinical skills needed for implant dentistry," said Dr. Neil Park, vice president of clinical affairs at Glidewell. "But mastering management and communication skills is just as important in establishing a successful implant practice. In partnership with top experts in the field, we have put together this program to fill in those important non-clinical skills."

To sign up for and learn more about the Glidewell Implant Business Essentials Continuum, visit glidewell.com/ibec or call 866-791-8539.

Ultradent Products, Inc., a leading developer and manufacturer of high-tech dental materials and equipment, has purchased majority ownership of Vamasa SA de CV, a premier distributor of dental products in Mexico. 

“We are proud to grow with Vamasa, with whom we have had a strong commercial relationship for nearly 30 years,” says Ultradent President and CEO Dirk Jeffs. “Ultradent is continually searching for new ways to improve oral health globally and this agreement will help us pursue that mission.”

The addition of Vamasa’s impressive network of suppliers, dealers and clinicians, as well as their infrastructure will assist Ultradent’s ability to better serve dentists in Latin America. Both companies share similar vision, values, innovative spirit, and commitment to those they serve and employ. These parallels create a unique opportunity to support the dental market in Mexico. 

“We are delighted to form this alliance, which is the result of many years of working in partnership with shared principles and values between the two companies,” says Vamasa Co-Founder Luis Vazquez. “Now, our distribution network will grow even stronger—and most importantly, we will work together for the benefit of dentists and patients in Mexico.”

About Ultradent Products, Inc.

Ultradent Products, Inc., is a leading developer and manufacturer of high-tech dental materials, devices, and instruments worldwide. Ultradent’s vision is to improve oral health globally. Ultradent also works to improve the quality of life and health of individuals through financial and charitable programs. For more information about Ultradent, call 800.552.5512, visit ultradent.com or find us on LinkedIn, Facebook, and Instagram. 

About Vamasa SA de CV

Vamasa SA de CV is the preeminent distributor of dental products in Mexico. Vamasa continually strives to uphold its values of integrity, teamwork, respect, responsibility, honesty, and altruism, while providing clinicians with a wide range of products from world-renowned and award-winning brands. For more, visit vamasa.com.mx or call + 52 81 83 11 11 11.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced in association with the American Association of Endodontists (AAE) Annual Meeting beginning on April 21, 2021, the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device for endodontists. This new Microfluidic Irrigation device is being developed to offer a solution for endodontists seeking more from their current cleaning and disinfection techniques, such as sodium hypochlorite, ethylenediaminetetraacetic acid, chlorhexidine or 2-in-1 or 3-in-1 irrigation solutions. BIOLASE anticipates submitting a premarket notification (510(k)) to the Food and Drug Administration for the co-developed device in the second quarter of 2021. The device is not currently available for sale in the United States.

The EdgePRO Laser-Assisted Microfluidic Irrigation device will build upon BIOLASE’s patented and proven platform that has been shown to significantly improve debridement1, cleaning and disinfection up to 99%2-4, and removes smear layer 5-9 and biofilms10,11 using the most advanced laser light sound technology with traditional irrigation solutions.

“We had been researching advanced Microfluidic Irrigation technologies in the high-tech endodontic irrigation market for several years and concluded that BIOLASE would be an ideal business partner for EdgeEndo,” said Dr. Charles Goodis, DDS, EdgeEndo founder and CEO. “Their proprietary Waterlase Er,Cr:YSGG technology has proven to be clinically effective in endodontics over the last 20 years. This is reinforced by the publication of more than 75 research papers and the technology’s use by thousands of dentists around the world to enhance clinical outcomes. Partnering with BIOLASE will provide us with access to an endodontic-specific, minimally invasive technology, with proprietary and patented radial firing tip technology to incorporate into our EdgePRO product. We are excited about this collaboration and in the near term look forward to developing a technology for endodontists that has the potential to improve patient experiences and clinical outcomes.”

BIOLASE President and CEO, John Beaver adds, “We are very pleased with the efforts thus far on the design and performance of the EdgePRO as our first OEM laser product. Approximately 75% of all endodontists routinely use EdgeEndo endodontic files, burs, and bioceramics, providing reach and relationships with the endodontists that will further our goal of making Waterlase technology the standard of care in endodontics. This allows BIOLASE to focus its commercial channels on other specialties, such as periodontics and pediatrics, in addition to the approximately 200,000 general dentists in the United States. We look forward to a long and beneficial relationship with EdgeEndo.”

Supporting the needs of endodontists is part of BIOLASE's continued effort to help improve patient experiences and outcomes, while also educating providers on the benefits of dental lasers. This announcement comes on the heels of the recently developed Waterlase Endo Academy, open to all Waterlase endodontists. Learn more about the benefits of laser dentistry in endodontics at biolase.com/betterendo.

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times.

BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Darby Dental Supply has partnered with the Productive Dentist Academy (PDA) to give customers access to dental-specific consulting services and educational opportunities. Founded in 2004 by Dr. Bruce B. Baird and Victoria Peterson, SsD, PDA has been recognized by Inc. 5000 as one of the fastest growing private companies in America. PDA provides a full range of consulting, marketing, and learning services to help dental practices achieve better results and elevate patient experience. The new partnership embodies Darby’s holistic approach of going beyond supplies to offer innovative solutions that drive long-term practice success.

“Darby is committed to seeking out the most advanced and valuable solutions available in the industry,” said Michael Caputo, President of Darby Dental Supply. “We are excited to give customers access to PDA’s services that address the unique challenges dental practices face today.”

As an added bonus for Darby customers, PDA is offering a $700 scholarship to their popular “PDA Business Impact: Foundations Program.” The 2-month high intensity coaching program is led by CEO Victoria Peterson and empowers dental practice owners with tools to create a profitable, successful business. Hosted virtually, the course includes one-on-one coaching sessions, 10 dynamic peer learning sessions, a printed workbook, 8 hours of AGD CE and access to a private PDA online community.

“Darby Dental has built a trusted reputation of quality and service,” explains Victoria Peterson, CEO of PDA. “We are excited to deliver innovative solutions to doctors to help manage supply overhead and increase quality of care for their patients. Dr. Baird and I view this partnership as a way of bringing value to private practice owners.”

As a full-service supply and service provider, Darby continues to invest in growth initiatives and industry collaborations that provide added value for their customers. Named one of Long Island’s “Best Places to Work” in 2020 by Newsday, Darby has continued its dramatic growth over the past year, adding 5% to its workforce, expanding its distribution space by 120,000 square feet, and adding over 5,000 new products.

About Darby Dental Supply, LLC:

Darby Dental Supply, LLC, is one of the largest dental distributors in the United States, shipping over one million orders each year. Headquartered in Jericho, NY, the company was founded in 1947 and has expanded into seven sales offices and three fully automated distribution centers strategically positioned across the country. As a low impact solutions provider, Darby gives general practitioners and specialty dental practices convenient access to over 50,000 products without interrupting daily workflow. By focusing on world-class service, dedicated customer care and a progressive spirit, Darby helps dental practices across the country operate more efficiently. In addition to physical products, Darby provides innovative and forward-thinking solutions such as a technology services division, capital equipment division, surgical division, equipment repair services and a full line of private label products. For more information, please visit www.darby.com.

About Productive Dentist Academy:

Productive Dentist Academy (PDA), a national organization and four-time recipient of the Inc. 5000 fastest growing privately held companies in America, offers a full range of business consulting, marketing services, and continuing educational learning services for dentists and team. With over 35 years of experience leading successful dental practices, PDA co-founders Dr. Bruce B. Baird and Victoria Peterson, SsD, provide expert business, communication and marketing guidance for private practice owners and the dental industry at large. For more information, visit www.ProductiveDentist.com or call 1-800-757-6077 ext. 8.

At an upcoming webinar on April 21, 2021, Dr. Lars Sennerby will review his simplified protocols using Neoss ProActive® Edge Implants, which are designed to ensure predictable stability in challenging clinical cases. Neoss also announces, today, data recently published that demonstrates stability with 1-2 drills, equal or better than premium market leaders and this data includes soft or compromised bone.

"As a company, our customers rely on our high-quality products that are not complicated but simple to use and adopt in their practices where they see consistent results and success for their patients," said Mark Neri, President, Neoss U.S. Our customers' patients are our patients, and we follow their workflow from early planning to case acceptance and through the implant maintenance phase. In recent studies Neoss ProActive Edge implants have achieved equal or better implant stability than other implant brands when tested in a soft bone model. We are very thankful to our customers and key opinion leaders who have contributed their support of our Neoss ProActive system and welcome our colleagues to attend our next webinar on April 21st with Prof. Lars Sennerby."

"The things I really love with the Neoss ProActive Edge Implant are the primary stability and you can use fewer drills," said Dr. John Hodges. The primary stability also makes it fantastic for my 4+ full arch cases. It's really my go-to implant for that."

Promising Data Announced on Neoss ProActive Edge Implants:

Data from a recent EAO study shows that Neoss ProActive Edge Implants achieve equal or better implant stability than the top premium brand implants. In addition, Neoss ProActive Edge was the only implant that maintained outstanding implant stability in all situations, even with over-prepared osteotomies, making it highly predictable to use.

Neoss ProActive Edge Core Differentiators:

The predictability of the Neoss ProActive Edge implant has been further confirmed in a clinical use study. High primary stability was achieved for all implants, allowing for immediate or early load in support of single crowns, partial bridges as well as for full arch restorations. All implants remained in function during the entire one-year observation period with minimal (-0.5 mm) bone remodeling. Similar to all Neoss implants, Neoss ProActive Edge features the clinically proven super hydrophilic ProActive surface and the highly trusted NeoLoc® connection. One prosthetic platform across 3 implant ranges with one screwdriver connection.

Drilling Protocol Reducing Chair Time:

A revolutionary 1 to 2-step drilling protocol prepares the site with minimal bone removal giving clinicians immediate feedback during placement. The drills are directly matched to the implant and thread designs, making placement faster, simpler and reducing chair time.

Neoss ProActive Edge Background:

The Neoss ProActive Edge was first introduced was first introduced in the spring of 2020 and is the latest evolutionary step in the Neoss implant range. It combines outstanding initial stability with a uniquely simplified drilling protocol, ensuring that every procedure is performed with complete confidence. The proven Neoss ProActive surface and NeoLoc® connection in combination with the new evolutionary thread design and simplified drilling protocol ensures predictable stability in soft and hard bone types. Neoss ProActive Edge puts performance at the forefront. The Neoss implant range is one of the most successful in the market today.

LIVE Webinar: Prof. Lars Sennerby - At the cutting EDGE of implant dentistry.

Wednesday 21st April 2021 | 19:00 PM Central European Summer Time (CEST). Register here.

About Neoss

Neoss offers intelligent products that are intuitively simple to use. Our products allow dental professionals to provide reliable and cost-effective treatments to their patients with excellent long-term results. Leading the market with ingenuity and integrity, we strive to set new standards. In developing smart treatment solutions and working closely with each practice, Neoss makes the complex less complicated for our customers. To find out more about the Neoss ProActive Edge implant visit neoss.com/edge

Nobel Biocare and KaVo Imaging are announcing their latest software development for imaging, diagnostics, treatment planning, treatment delivery, and follow-up. Available in North America and selected European markets first, DTX Studio Clinic is developed to redefine connectivity and offer continuity of care for all patients in the dental office, during all visits, and for the entire dental treatment team.

DTX Studio Clinic 1.8 is designed to speed up and manage daily imaging procedures in one software, through fast intraoral X-ray diagnostic workflows. Both healthcare professionals and distributing partners benefit from a simplified and comprehensive software landscape.

DTX Studio Clinic, part of the DTX Studio suite, is an open, interactive, and dynamic imaging software platform with impressive navigation across imaging modalities: 2D and 3D, X-ray, and optical patient image data from various sources. Clinicians will benefit from how the software intuitively allows for seamless image acquisition, diagnostics, organization, cooperation, and treatment workflows in a single environment – for every patient visit.

Convenient Clinical Decision Making

DTX Studio Clinic is a software dedicated to support everyday patient diagnostics. It offers a clear, clean interface with multiple workspaces to assist with accurate and fast diagnostics. From photos, clinical images, intraoral, panoramic and cephalometric X-rays to CBCT and Intraoral optical scans, all types of images can be displayed on the same screen at the same time. The side-by-side display allows for quick identification of dental anatomy changes, which helps to support diagnostics, treatment progress, and patient follow-up.

Delivering Dental Treatments

During each appointment, the patient’s imaging history and present situation guide the next steps. Dental professionals continuously act on findings from the patient's visual record and with the help of DTX Studio Clinic, they finally have all collected information conveniently structured and always retrievable at their fingertips.

Streamlined Implant Planning

Improving workflow within the office is key to a better work environment. From implantologists who are just beginning to use DTX Studio Clinic to those who are experienced – and also using DTX Studio Implant – DTX Studio suite offers customized workflows to accommodate the clinician’s current and future skillsets. The DTX Studio Implant module facilitates the visualization of critical information for detailed implant planning according to the desired prosthetic outcome. Tools for enhanced collaboration with the dental technician make it simple for the clinician to offer patients a CAD/CAM provisional restoration on the day of surgery. For dental laboratories, the DTX Studio Lab design module combines powerful CAD tools with an intuitive interface. It enables quick and easy design of the desired restoration, whether tooth- or implant based.

Endless Possibilities

Owing to the ever-changing dental technology market, DTX Studio Clinic was developed to support clinicians’ current and future needs. As an open software solution, it connects to KaVo’s imaging devices, but also accepts images from any X-ray device, intraoral optical scanner, desktop scanner or camera, supporting open industry standard formats, like DICOM, PNG, BMP, JPG, STL, PLY or the TWAIN protocol. Full support for Windows® PC and Mac operating systems, make DTX Studio Clinic an ideal fit for any practice.

Mac Compatibility

To better serve Mac users, DTX Studio Clinic combines elegance and intuitiveness with a native MacOS version. The consistency in the DTX Studio Clinic user interface, operation, and appearance provide a feeling of familiarity regardless of the imaging devices being used or the treatments being planned.

Dr. Pascal Kunz, Vice President for Digital Solutions, said:

“Nobel Biocare and KaVo Imaging, both innovators and pioneers in computer-assisted surgeries and dental imaging, have joined forces to create the DTX Studio ecosystem. DTX Studio Clinic establishes a new benchmark in dental imaging. It offers continuity in diagnostics, treatments, and treatment workflows by following a truly open approach. It invites industry partners to collaborate and master all imaging modalities in one place, for all dental specialties. Our goal is to simplify the interaction with imaging, digital technology, and make relevant information easily accessible for more efficient and predictable treatments.”

About Nobel Biocare

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive® and NobelParallel™ and ceramic implant NobelPearl™*) a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), digital solutions for treatment planning and guided surgery (NobelClinician® and DTX Studio suite) as well as biomaterials. Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. *Distributed by Nobel Biocare. Manufactured by Dentalpoint AG

For more information, visit www.nobelbiocare.com, and follow us on Facebook, Twitter, LinkedIn, Instagram and YouTube.

About KaVo

KaVo is a premier dental solutions provider committed to exceptional customer experience. The brand was established in 1909 in Berlin with the motto of “Quality and precision”, which continues to be the foundation for our continued excellence and innovation. KaVo has a long history of innovation, commitment to Dental Excellence, and a common purpose of enabling healthy, beautiful smiles. The KaVo portfolio of dental diagnosis and treatment solutions includes digital imaging solutions, treatment units, laboratory equipment, and practice education. Marquee dental equipment brands include DEXIS, i-CAT, Gendex, and NOMAD.

For more information, visit www.KaVoKerr.com, like us at www.Facebook.com/KaVoKerr, and follow us at www.Instagram.com/kavokerr.

Forward-Looking Statement

This press release contains statements that constitute forward-looking statements. Statements can generally be identified as forward-looking because they include words such as “believes,” “anticipates,” “expects,” “would,” “could,” or words of similar meaning. Statements that describe future plans and objectives are also forward-looking statements. These statements are based on the companies’ current expectations and beliefs and are subject to a number of trends and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements; KaVo and Nobel Biocare can give no assurance that their expectations will be attained.